300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
SaaS
Photography
Restaurants
Email
Payments
Energy
CleanTech
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Mobile
Automotive
Wellness
Sports
Legal
Education
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Medical
Cannabis
Recruiting
LGBT
Celebrity
Climate
Web3
Mobile Apps
Life Science
Wine and Spirits
Music
Food and Beverage
Publishing
Art
Manufacturing
Digital Media
Real Estate
FinTech
Finance
Financial Services
Sporting Goods
Social Media
Franchise
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Romania
Pakistan
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Moldova
Uruguay
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
United Kingdom
Ghana
Iraq
Mali
Malaysia
Latvia
Portugal
Sierra Leone
Rwanda
Philippines
El Salvador
Tanzania
Senegal
Germany
India
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Cyprus
Belgium
Barbados
Jordan
Austria
Qatar
Ethiopia
Bulgaria
Azerbaijan
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Ecuador
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Forty51 Ventures, VC Fund

Forty51 Ventures

VC Fund

Forty51 Ventures is a VC fund focused on Therapeutics and Medical. Forty51 Ventures is the Biotech Venture Capital.

Total investments:
7
Last investment:
Lead investor:
57%

Last updated:

Industries Forty51 Ventures invests in

TherapeuticsMedicalHealth CareBiotechnology

Stages Forty51 Ventures invests in

SeedSeries A

Countries Forty51 Ventures invests in

Switzerland

Round sizes

Seed $3.5M–$5.1M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Round size

Seed
$3.5M–$5.1M

Investment Focus

Industry

  • Therapeutics 2 (29%)
  • Medical 1 (14%)
  • Health Care 1 (14%)
  • Biotechnology 1 (14%)

Stage

  • Seed 4 (57%)
  • Series A 1 (14%)

Team

NameTitleInvestmentsLinksEmail
Partner Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
Ferrosa Therapeutics Ferrosa Therapeutics
Ferrosa Therapeutics is a Basel, Switzerland-based biotechnology company developing a first-in-class bispecific antibody to treat anemia of inflammation. $3.5M / Seed / Apr 23, 2026
Allegria Therapeutics Allegria Therapeutics
Allegria Therapeutics operates as a biotech company. $5.1M / Seed / Dec 11, 2025
Mosanna Therapeutics Mosanna Therapeutics
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. $80M / Series A / Jun 09, 2025
Allegria Therapeutics Allegria Therapeutics
Allegria Therapeutics operates as a biotech company. $3.5M / Seed / May 06, 2024
Mysthera Therapeutics Mysthera Therapeutics
Mysthera Therapeutics is a pharmaceutical company Mysthera plans to reshape the treatment landscape for autoimmune disease. PIM kinase inhibition uniquely and selectively modulates immune cell function in multiple lineages associated with complex disease. $3.5M / Seed / Aug 21, 2023
Mosanna Therapeutics Mosanna Therapeutics
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. Seed / Apr 11, 2023
Mosanna Therapeutics Mosanna Therapeutics
Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. Seed / Jul 13, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
SaaS
Photography
Restaurants
Email
Payments
Energy
CleanTech
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Blockchain
Facebook
B2B
Social Network
Video Games
Big Data
Medical Device
Mobile
Automotive
Wellness
Sports
Legal
Education
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Theatre
Infrastructure
Medical
Cannabis
Recruiting
LGBT
Celebrity
Climate
Web3
Mobile Apps
Life Science
Wine and Spirits
Music
Food and Beverage
Publishing
Art
Manufacturing
Digital Media
Real Estate
FinTech
Finance
Financial Services
Sporting Goods
Social Media
Franchise
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Romania
Pakistan
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Luxembourg
Marshall Islands
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Morocco
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Moldova
Uruguay
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
Canada
France
Georgia
Denmark
United Kingdom
Ghana
Iraq
Mali
Malaysia
Latvia
Portugal
Sierra Leone
Rwanda
Philippines
El Salvador
Tanzania
Senegal
Germany
India
United States
Indonesia
Dominican Republic
Middle East
Bermuda
Albania
Asia
Spain
Argentina
Bangladesh
Angola
Europe
Cyprus
Belgium
Barbados
Jordan
Austria
Qatar
Ethiopia
Bulgaria
Azerbaijan
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Ecuador
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lithuania
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Forty51 Ventures invest in?

Forty51 Ventures invests primarily in Therapeutics, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Forty51 Ventures's check size?

Forty51 Ventures typically joins rounds of $3.5M–$5.1M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Forty51 Ventures participates in.

How do I contact Forty51 Ventures?

Public channels for Forty51 Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Forty51 Ventures?

The team at Forty51 Ventures includes Tamas Schweighoffer (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Forty51 Ventures Forty51 Ventures Find emails